• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清骨保护素与人类颈动脉斑块回声呈负相关。

Serum osteoprotegerin is inversely associated with carotid plaque echogenicity in humans.

作者信息

Vik Anders, Mathiesen Ellisiv B, Notø Ann-Trude W, Sveinbjørnsson Baldur, Brox Jan, Hansen John-Bjarne

机构信息

Center for Atherothrombotic Research in Tromsø (CART), Department of Medicine, Institute of Clinical Medicine, University of Tromsø, N-9037 Tromsø, Norway.

出版信息

Atherosclerosis. 2007 Mar;191(1):128-34. doi: 10.1016/j.atherosclerosis.2006.03.002. Epub 2006 Apr 18.

DOI:10.1016/j.atherosclerosis.2006.03.002
PMID:16620835
Abstract

Osteoprotegerin (OPG) is a member of the tumour necrosis factor superfamily involved in the regulation of bone metabolism and vascular calcification. High serum values of OPG are associated with cardiovascular disease in humans. The purpose was to investigate serum OPG levels in subclinical carotid atherosclerosis and the relation between OPG levels and plaque morphology. OPG levels were compared in 29 persons with echogenic carotid plaques, 30 persons with echolucent plaques and 41 persons without carotid plaques, all recruited from a population health study. Computerized assessment of plaque echogenicity was done by use of the gray scale median (GSM). Participants with echogenic carotid plaques had lower serum OPG level (1.23 ng/ml; 1.02-1.48) (geometric mean; 95% CI) than persons with echolucent plaques (1.76 ng/ml; 1.46-2.14) and those without plaques (1.89 ng/ml; 1.60-2.21). OPG and PTH were independently related to GSM. A significant trend for decrease in GSM across quartiles of OPG was found (p=0.003) which remained significant even after adjustment for PTH and smoking. The present study demonstrates lower serum OPG levels in persons with subclinical echogenic carotid plaques and identified an inverse relation between serum OPG and plaque echogenicity. The findings support the concept that OPG may play an important role in arterial calcification.

摘要

骨保护素(OPG)是肿瘤坏死因子超家族的成员,参与骨代谢和血管钙化的调节。人类血清中高水平的OPG与心血管疾病相关。本研究旨在调查亚临床颈动脉粥样硬化患者的血清OPG水平,以及OPG水平与斑块形态之间的关系。从一项人群健康研究中招募了29例有强回声颈动脉斑块的患者、30例有低回声斑块的患者和41例无颈动脉斑块的患者,并比较他们的OPG水平。通过使用灰度中位数(GSM)对斑块回声进行计算机评估。有强回声颈动脉斑块的参与者血清OPG水平(几何平均数为1.23 ng/ml;95%置信区间为1.02 - 1.48)低于有低回声斑块的患者(1.76 ng/ml;1.46 - 2.14)和无斑块的患者(1.89 ng/ml;1.60 - 2.21)。OPG和甲状旁腺激素(PTH)与GSM独立相关。在OPG的四分位数中发现GSM有显著下降趋势(p = 0.003),即使在对PTH和吸烟进行校正后,该趋势仍具有显著性。本研究表明,有亚临床强回声颈动脉斑块的患者血清OPG水平较低,并确定了血清OPG与斑块回声之间呈负相关。这些发现支持了OPG可能在动脉钙化中起重要作用的观点。

相似文献

1
Serum osteoprotegerin is inversely associated with carotid plaque echogenicity in humans.血清骨保护素与人类颈动脉斑块回声呈负相关。
Atherosclerosis. 2007 Mar;191(1):128-34. doi: 10.1016/j.atherosclerosis.2006.03.002. Epub 2006 Apr 18.
2
The relationship between serum levels of vascular calcification inhibitors and carotid plaque vulnerability.血清血管钙化抑制剂水平与颈动脉斑块易损性之间的关系。
J Vasc Surg. 2008 Jan;47(1):55-62. doi: 10.1016/j.jvs.2007.09.058.
3
Intensive lipid-lowering therapy ameliorates novel calcification markers and GSM score in patients with carotid stenosis.强化降脂治疗可改善颈动脉狭窄患者的新型钙化标志物和GSM评分。
Eur J Vasc Endovasc Surg. 2008 Jun;35(6):661-8. doi: 10.1016/j.ejvs.2007.12.011. Epub 2008 Apr 18.
4
Assessment of the genetic effects of polymorphisms in the osteoprotegerin gene, TNFRSF11B, on serum osteoprotegerin levels and carotid plaque vulnerability.评估骨保护素基因、TNFRSF11B 多态性对血清骨保护素水平和颈动脉斑块易损性的遗传影响。
Stroke. 2011 Nov;42(11):3022-8. doi: 10.1161/STROKEAHA.111.619288. Epub 2011 Sep 8.
5
Beneficial changes of serum calcification markers and contralateral carotid plaques echogenicity after combined carotid artery stenting plus intensive lipid-lowering therapy in patients with bilateral carotid stenosis.双侧颈动脉狭窄患者行颈动脉支架置入术联合强化降脂治疗后血清钙化标志物和对侧颈动脉斑块回声变化的有益改变。
Eur J Vasc Endovasc Surg. 2010 Mar;39(3):258-65. doi: 10.1016/j.ejvs.2009.11.013. Epub 2009 Dec 8.
6
Elastin and calcium rather than collagen or lipid content are associated with echogenicity of human carotid plaques.与人类颈动脉斑块的回声性相关的是弹性蛋白和钙,而非胶原蛋白或脂质含量。
Stroke. 2004 Dec;35(12):2795-800. doi: 10.1161/01.STR.0000147038.12073.59. Epub 2004 Oct 28.
7
Computer-assisted characterisation of a carotid plaque.计算机辅助颈动脉斑块特征分析。
Med Sci Monit. 2004 Jun;10 Suppl 3:67-70.
8
Circulating osteoprotegerin and asymptomatic carotid atherosclerosis in postmenopausal non diabetic women.绝经后非糖尿病女性循环骨保护素与无症状颈动脉粥样硬化。
Adv Med Sci. 2014 Sep;59(2):293-8. doi: 10.1016/j.advms.2014.08.002. Epub 2014 Sep 11.
9
Computer-assisted ultrasonographic analysis of carotid plaques in relation to cerebrovascular symptoms, cerebral infarction, and histology.计算机辅助超声分析颈动脉斑块与脑血管症状、脑梗死及组织学的关系。
Ann Vasc Surg. 2000 Mar;14(2):130-7. doi: 10.1007/s100169910024.
10
Serum osteoprotegerin concentration is associated with carotid atherosclerotic plaque in patients with rheumatoid arthritis.血清护骨素浓度与类风湿关节炎患者颈动脉粥样硬化斑块有关。
Mod Rheumatol. 2013 Mar;23(2):269-75. doi: 10.1007/s10165-012-0654-5. Epub 2012 May 15.

引用本文的文献

1
Osteoprotegerin as an Emerging Biomarker of Carotid Artery Stenosis? A Scoping Review with Meta-Analysis.骨保护素作为颈动脉狭窄的一种新兴生物标志物?一项包含荟萃分析的范围综述。
Diagnostics (Basel). 2025 Jan 19;15(2):219. doi: 10.3390/diagnostics15020219.
2
The role of the osteoprotegerin/RANKL/RANK axis and osteopontin in acute coronary syndrome.骨保护素/核因子κB受体活化因子配体/核因子κB受体活化因子轴及骨桥蛋白在急性冠状动脉综合征中的作用
Arch Cardiol Mex. 2024 May 29;95(1):1-8. doi: 10.24875/ACM.24000037.
3
The Effect of PCSK9 Inhibition on the Stabilization of Atherosclerotic Plaque Determined by Biochemical and Diagnostic Imaging Methods.
PCSK9 抑制剂对动脉粥样硬化斑块稳定性的影响:生化和诊断影像学方法的评估。
Molecules. 2023 Aug 7;28(15):5928. doi: 10.3390/molecules28155928.
4
Bone mass density and bone metabolism marker are associated with progression of carotid and cardiac calcified plaque in Chinese elderly population.骨密度和骨代谢标志物与中国老年人群颈动脉和心脏钙化斑块的进展有关。
Osteoporos Int. 2019 Sep;30(9):1807-1815. doi: 10.1007/s00198-019-05031-5. Epub 2019 Jun 10.
5
Predictors for major cardiovascular outcomes in stable ischaemic heart disease (PREMAC): statistical analysis plan for data originating from the CLARICOR (clarithromycin for patients with stable coronary heart disease) trial.稳定型缺血性心脏病主要心血管结局的预测因素(PREMAC):来自CLARICOR(克拉霉素用于稳定型冠心病患者)试验数据的统计分析计划
Diagn Progn Res. 2017 Mar 29;1:10. doi: 10.1186/s41512-017-0009-y. eCollection 2017.
6
Osteoprotegerin and Cardiovascular Events in High-Risk Populations: Meta-Analysis of 19 Prospective Studies Involving 27 450 Participants.骨保护素与高危人群心血管事件:19 项前瞻性研究、27450 名参与者的荟萃分析。
J Am Heart Assoc. 2018 Aug 21;7(16):e009012. doi: 10.1161/JAHA.118.009012.
7
Serum osteoprotegerin and renal function in the general population: the Tromsø Study.普通人群中的血清骨保护素与肾功能:特罗姆瑟研究
Clin Kidney J. 2017 Feb;10(1):38-44. doi: 10.1093/ckj/sfw095. Epub 2016 Oct 3.
8
Correlation of plasma osteoprotegerin (OPG) and receptor activator of the nuclear factor κB ligand (RANKL) levels with clinical risk factors in patients with advanced carotid atherosclerosis.探讨晚期颈动脉粥样硬化患者血浆护骨素(OPG)和核因子κB 受体激活剂配体(RANKL)水平与临床危险因素的相关性。
Med Sci Monit. 2012 Oct;18(10):CR597-604. doi: 10.12659/msm.883485.
9
Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications.钙、维生素 D 和抗骨质疏松药物的骨骼外获益与风险。
Osteoporos Int. 2012 Feb;23 Suppl 1(Suppl 1):S1-23. doi: 10.1007/s00198-011-1891-8. Epub 2012 Feb 4.
10
The apolipoprotein C-I content of very-low-density lipoproteins is associated with fasting triglycerides, postprandial lipemia, and carotid atherosclerosis.极低密度脂蛋白中的载脂蛋白C-I含量与空腹甘油三酯、餐后血脂异常及颈动脉粥样硬化相关。
J Lipids. 2011;2011:271062. doi: 10.1155/2011/271062. Epub 2011 Jul 6.